Captor Therapeutics Spolka Akcyjna (CTX.WA)
PLN 42.0
(-3.89%)
PLN 42.0
(-3.89%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | - PLN | -100.0% |
| 2022 | 1.00 PLN | 0.0% |
| 2021 | - PLN | 0.0% |
| 2020 | - PLN | -100.0% |
| 2019 | 471 Thousand PLN | 47.65% |
| 2018 | 319 Thousand PLN | 161.94% |
| 2017 | -515 Thousand PLN | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | - PLN | -589900100.0% |
| 2024 Q1 | 1.00 PLN | 0.0% |
| 2023 Q3 | 412 Thousand PLN | 41199900.0% |
| 2023 Q2 | 1.00 PLN | 0.0% |
| 2023 FY | - PLN | -100.0% |
| 2023 Q4 | - PLN | -100.0% |
| 2023 Q1 | - PLN | -100.0% |
| 2022 Q1 | -769 Thousand PLN | 21.05% |
| 2022 Q4 | 1.00 PLN | -100.0% |
| 2022 FY | 1.00 PLN | 0.0% |
| 2022 Q3 | 10.63 Million PLN | 1099.44% |
| 2022 Q2 | -1.06 Million PLN | -38.36% |
| 2021 Q2 | -5.17 Million PLN | 0.0% |
| 2021 FY | - PLN | 0.0% |
| 2021 Q1 | - PLN | 0.0% |
| 2021 Q4 | -974 Thousand PLN | 0.71% |
| 2021 Q3 | -981 Thousand PLN | 81.05% |
| 2020 FY | - PLN | -100.0% |
| 2020 Q2 | - PLN | 0.0% |
| 2020 Q4 | - PLN | 0.0% |
| 2019 FY | 471 Thousand PLN | 47.65% |
| 2019 Q4 | - PLN | 0.0% |
| 2018 FY | 319 Thousand PLN | 161.94% |
| 2017 FY | -515 Thousand PLN | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Bioceltix S.A. | 8617.89 PLN | 100.0% |
| BIOTON S.A. | 117.91 Million PLN | 100.0% |
| Mabion S.A. | 6.84 Million PLN | 100.0% |
| Molecure S.A. | - PLN | NaN% |
| NanoGroup S.A. | 63.37 Thousand PLN | 100.0% |
| Pharmena S.A. | 445 Thousand PLN | 100.0% |
| Poltreg S.A. | 415 Thousand PLN | 100.0% |
| Pure Biologics Spólka Akcyjna | 17.56 Million PLN | 100.0% |
| Ryvu Therapeutics S.A. | 2.11 Million PLN | 100.0% |
| Synthaverse S.A. | 15.48 Million PLN | 100.0% |
| Urteste S.A. | 162 Thousand PLN | 100.0% |